Evaluation of dimethoxydop-NU as a novel anti-tumor agent. | J Exp Clin Cancer Res;26(4): 489-97, 2007 Dec. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL TCIM Americas

Traditional, Complementary and Integrative Medicine in the Americas VHL

Subject descriptor lookup Advanced Search

Evaluation of dimethoxydop-NU as a novel anti-tumor agent.

Mukherjee, A; Dutta, S; Sanyal, U.

Affiliation

Mukherjee A; Department of Anticancer Drug Development, Chittaranjan National Cancer Institute, Kolkata, India.

J Exp Clin Cancer Res ; 26(4): 489-97, 2007 Dec.

Article in En | MEDLINE | ID: mdl-18365543

Subject(s)

Antineoplastic Agents/pharmacology; Nitrosourea Compounds/pharmacology; Animals; Cell Line, Tumor; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Humans; Mice; Nitrosourea Compounds/chemical synthesis; Thymidine/metabolism; Uridine/metabolism

Search on Google

Database: MEDLINE Main subject: Antineoplastic Agents / Nitrosourea Compounds Type of study: Guideline Language: En Journal: J Exp Clin Cancer Res Year: 2007 Type: Article Affiliation country: India

Search on Google

Database: MEDLINE Main subject: Antineoplastic Agents / Nitrosourea Compounds Type of study: Guideline Language: En Journal: J Exp Clin Cancer Res Year: 2007 Type: Article Affiliation country: India